首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >A new candidate for insulinomimetic vanadium complex: synergism of oxovanadium(IV)porphyrin and sodium ascorbate.
【24h】

A new candidate for insulinomimetic vanadium complex: synergism of oxovanadium(IV)porphyrin and sodium ascorbate.

机译:拟胰岛素钒配合物的新候选物:氧钒(IV)卟啉和抗坏血酸钠的协同作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Vanadyl-meso-tetrakis(1-methylpyridinium-4-yl)porphyrin, VOTMpyP with the VO(N(4)) coordination mode, was found to have a potent insulinomimetic activity on the basis of in vitro and in vivo experiments. When the complex was given simultaneously with sodium ascorbate, the high blood glucose levels of type 1 diabetic model STZ-rats were lowered by synergistic effect, probably sustaining the vanadyl state by means of ascorbate distributed in the organs and tissues of animals. This is the first finding on not only the insulinomimetic vanadyl-porphyrin complex but also the occurrence of a synergistic effect of VOTMpyP and sodium ascorbate to lower the high blood glucose levels in diabetic animals.
机译:钒氧-间-四(1-甲基吡啶-4-基)卟啉,具有VO(N(4))配位模式的VOTMpyP,在体外和体内实验的基础上具有强大的胰岛素模拟活性。当将复合物与抗坏血酸钠同时给药时,通过协同作用降低了1型糖尿病模型STZ-大鼠的高血糖水平,可能通过分布在动物器官和组织中的抗坏血酸维持了钒的状态。这不仅是拟胰岛素的钒基-卟啉复合物的首次发现,而且是VOTMpyP和抗坏血酸钠降低糖尿病动物高血糖水平协同作用的发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号